AlphAIalphai — Financial news for AI agents
StockNASDAQ · US · USDHealthcare · BIOTECHNOLOGY

$HYFT

MindWalk Holdings Corp.

Insider trades
Price · $HYFTvia TradingView
AI sentiment · 7d1 articles
AUG 6net (bullish − bearish)AUG 12
Bullish
1
Neutral
0
Bearish
0
Insider · 30dAll trades →

No SEC Form 4 filings for $HYFT in the last 30 days.

See all $HYFT insider activity →
Top stories · $HYFTMore →
AUG 10·leaderpost.comLow

AI Found an Influenza Target That Survives Viral Mutation

MindWalk Holdings Corp. (Nasdaq: HYFT) says its Bio-Native AI platform identified a conserved influenza biological signature that remains consistent despite major viral genetic changes. The company demonstrated ReefIQ on AMD Instinct accelerators at AMD’s Advancing AI 2026 event on July 23, 2026. MindWalk is shifting from platform-only to building pipeline assets and reports LensAI has contracted recurring arrangements.

JUL 24·leaderpost.com

A Small AI Company Just Took the Stage at One of the Biggest Events in Computing, and It Points to Where Drug Discovery Is Headed

MindWalk Holdings Corp. (NASDAQ: HYFT) showcased ReefIQ, its biological context layer for AI drug discovery, at AMD’s Advancing AI 2026 in San Francisco, running on AMD Instinct. The company said ReefIQ reconnects fragmented discovery data into governed, queryable context for AI reasoning. It also cited HYFT’s 660 million patterns and 25 billion relationships and said LensAI is in recurring customer contracts.

HYFT sentiment & insider activity

Over the past 7 days, alphai's AI scored 1 news story mentioning HYFT (MindWalk Holdings Corp.). Coverage has skewed bullish: 1 bullish, 0 neutral, and 0 bearish.

Recent HYFT coverage spans technology, earnings and financial news.

What's driving HYFT

  • Potential positive read-through for HYFT’s platform credibility and universal-influenza program, but the article provides no clinical efficacy or funding terms.

    leaderpost.com · Aug 10, 2026

  • The article is a product-stage milestone for HYFT, but it provides no commercial metrics, customer names, or performance results.

    leaderpost.com · Jul 24, 2026

  • The first recurring platform contracts plus revenue growth and margin expansion are a meaningful business-model inflection for HYFT.

    prnewswire.com · Jul 23, 2026

  • Results and pivot narrative suggest improving operating leverage and early recurring platform traction, which can re-rate near-term expectations.

    finanznachrichten.de · Jul 22, 2026

  • Near-term catalyst is the July 22 earnings print, with potential sentiment swing from platform revenue trajectory, partner engagement, and balance-sheet impact after the Netherlands divestiture.

    leaderpost.com · Jul 15, 2026

alphai scores every news story that mentions HYFT with an AI model for sentiment and relevance, and aggregates insider trades from MindWalk Holdings Corp.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $HYFT

Score
AUG 10$HYFTLowleaderpost.com

AI Found an Influenza Target That Survives Viral Mutation

MindWalk Holdings Corp. (Nasdaq: HYFT) says its Bio-Native AI platform identified a conserved influenza biological signature that remains consistent despite major viral genetic changes. The company demonstrated ReefIQ on AMD Instinct accelerators at AMD’s Advancing AI 2026 event on July 23, 2026. MindWalk is shifting from platform-only to building pipeline assets and reports LensAI has contracted recurring arrangements.

6 min read
JUL 24$HYFTLowleaderpost.com

A Small AI Company Just Took the Stage at One of the Biggest Events in Computing, and It Points to Where Drug Discovery Is Headed

MindWalk Holdings Corp. (NASDAQ: HYFT) showcased ReefIQ, its biological context layer for AI drug discovery, at AMD’s Advancing AI 2026 in San Francisco, running on AMD Instinct. The company said ReefIQ reconnects fragmented discovery data into governed, queryable context for AI reasoning. It also cited HYFT’s 660 million patterns and 25 billion relationships and said LensAI is in recurring customer contracts.

7 min read
JUL 23$HYFTMedAI 8/10prnewswire.com

An AI Biotech Just Reported a 46% Revenue Jump and Its First Recurring Platform Contracts, as Its Pivot Starts Showing Up in the Numbers

MindWalk Holdings Corp. (Nasdaq: HYFT) reported fiscal 2026 results for the year ended Apr 30, 2026. Revenue rose 46% to C$15.6M, gross margin increased to 58.8%, and net loss narrowed to C$13.9M. The company said it signed its first two contracted recurring LensAI™ platform agreements and regained Nasdaq compliance.

4 min read
JUL 22$HYFTMedfinanznachrichten.de

MindWalk Holdings Corp. Reports Fiscal 2026 Results: Revenue Up 46% as the Company Completes Its Pivot to Bio-Native AI Infrastructure

MindWalk Holdings Corp. (NASDAQ: HYFT) reported fiscal 2026 results for the year ended April 30, 2026. Revenue rose 46% to $15.6 million and gross margin increased to 59%. Net loss narrowed to $13.9 million from $30.2 million. The company said it completed a pivot to BioIntelligence infrastructure, divested a Netherlands unit, and launched ReefIQ in June 2026.

7 min read
JUL 15$HYFTMedleaderpost.com

As AI Rewrites Drug Discovery, This Bio-Native AI Company Just Joined the Russell 3000E, and Reports Earnings July 22

MindWalk Holdings Corp. (NASDAQ: HYFT) said it was added to the Russell 3000E effective June 26, 2026, and plans to report Q4 and full fiscal 2026 results July 22, 2026. The company reported Q2 FY2026 revenue of about $3.0M (up 54% YoY) and filed a European patent covering its HYFT technology and ReefIQ layer. It is pursuing GLP-1 and infectious disease programs.

6 min read
JUL 6$HYFTLowthestarphoenix.com

As AI Models Become Commodities, a Bio-Native AI Company Just Moved to Patent the Data Layer Beneath the Models

MindWalk Holdings (NASDAQ: HYFT) filed a European patent application (EP26187897.9) to protect high-dimensional biological data structures for subsequence/property inference that underpin its HYFT Technology, ReefIQ context layer, and LensAI reasoning workflows. The company says it builds on its WO 2020/161344 patent and aims to preserve traceable biological context as AI models become interchangeable.

5 min read
JUL 1$HYFTLowfinanznachrichten.de

MindWalk Holdings Corp.: MindWalk (NASDAQ: HYFT) Files Patent for High-Dimensional Biological Data Architecture Powering AI Drug Discovery

MindWalk Holdings (NASDAQ: HYFT) said it filed a European patent application (EP26187897.9) covering a high-dimensional biological data architecture for its HYFT Technology, including a model-agnostic context layer for ReefIQ and LensAI workflows. The company links the filing to its earlier HYFT patent (EP3881326A1) and cites preclinical dengue and influenza program data.

3 min read

Related tickers

More in BIOTECHNOLOGY